| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/09/2003 | EP1299535A2 Peptide extended glycosylated polypeptides |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299530A2 Novel compounds |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299407A2 Maize glutamine synthetase gene promoter |
| 04/09/2003 | EP1299168A1 Mini-cyclone biocollector and concentrator |
| 04/09/2003 | EP1299111A1 METHOD FOR PRODUCING NEMATOCIDAL COMPOSITION BY HEAT TREATING A pH-ADJUSTED FERMENTATION BROTH |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1155139B1 Method for microbially producing l-valine |
| 04/09/2003 | EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 04/09/2003 | EP0806477B1 Use of a recombinant dna comprising dna coding for smooth muscle-type myosin heavy-chain sm1 isoform protein in the manufacture of a medicament |
| 04/09/2003 | EP0780477B1 Process for producing l-lysine and l-glutamic acid by fermentation |
| 04/09/2003 | EP0708834B1 Formation of and methods for the production of large (bacillus thuringiensis) crystals with increased pesticidal activity |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | CN2543962Y 反应器 Reactor |
| 04/09/2003 | CN1409769A Method for continuous cultivation of microorganisms of genus eremothecium |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409759A Compositions and methods for halogenation reactions |
| 04/09/2003 | CN1409756A Sterilized microbial cells |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1408877A Method for preparing target matter |
| 04/09/2003 | CN1408876A Chick pea kluyveromyces expression system and its use |
| 04/09/2003 | CN1408873A process for efficiently purifying gene engineering bacteria recombination expression product and its use |
| 04/09/2003 | CN1408863A Human interleukin-10 gene sequenc and E coli containing the said gene sequence |
| 04/09/2003 | CN1408862A Artificial synthetic beta-interferon gene and its expression carrier |
| 04/09/2003 | CN1408849A Process for preparing recombination human glicentin-1(7-37) |
| 04/09/2003 | CN1408848A Immobile bacillus and method for resolving and preparing chiral cyclopentenylone using said bacillus |
| 04/09/2003 | CN1408847A Pantemperature streptomycete C-3662 capable of secreting proteinase with fibrinolytic activity |
| 04/09/2003 | CN1408846A Penicillium commune |
| 04/09/2003 | CN1408726A Preparation of non-mitogenic recombination acid fibrolast growth factor (aFGF) mutant |
| 04/09/2003 | CN1408242A Technology for producing microbial fodder strengthening agent |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/09/2003 | CN1105186C Gene imparting flocculability to yeast and gene product |
| 04/09/2003 | CN1105184C Enzyme with protease activity |
| 04/09/2003 | CN1104907C Vibrio cholerae 01 (CVD111) and Non-01 (CVD112 and CVD112 RM) serogroup vaccine strain and methods of making same |
| 04/09/2003 | CN1104844C Oral composition for animals |
| 04/08/2003 | US6545141 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 04/08/2003 | US6545124 Antiproliferative agents |
| 04/08/2003 | US6544792 Deactivation; Bacillus culture product |
| 04/08/2003 | US6544774 Morphological mutants of filamentous fungi |
| 04/08/2003 | US6544772 Genetic engineering; isolated from Lctobacillus |
| 04/08/2003 | US6544767 Genetic engineering; isolated polypeptide |
| 04/08/2003 | US6544765 Oxaloacetate hydrolase deficient fungal host cells |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544758 Methods for expressing endostatin protein |
| 04/08/2003 | US6544756 Sorbitol dehydrogenase, microorganism for producing same, process for the production thereof, method for the measurement of sorbitol and reagent for the quantitative determination therefor |
| 04/08/2003 | US6544753 Dietetics; analgesics; cognition activators; detecting binding |
| 04/08/2003 | US6544733 Method of identifying non-host plant disease resistance genes |
| 04/08/2003 | US6544524 2-isopropyl-5-benzylidenedioxolan-4-one-2-carboxylic acid |
| 04/08/2003 | US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same |
| 04/08/2003 | US6544516 Treating with anitbodies for bactericidal activity against enterococci |
| 04/08/2003 | US6544510 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544509 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/08/2003 | US6544508 Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799) |
| 04/08/2003 | US6544505 Interferon-epsilon |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2163524C Assay and reagents for identifying anti-proliferative agents |
| 04/08/2003 | CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 04/03/2003 | WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 04/03/2003 | WO2003027306A2 Bgl3 beta-glucosidase and nucleic acids encoding the same |
| 04/03/2003 | WO2003027305A2 Optimization of temperature shifting in high cell-density fermentations |
| 04/03/2003 | WO2003027297A1 PROCESS FOR PRODUCING α2,3/α2,8-SIALYLTRANSFERASE AND SIALIC ACID-CONTAINING COMPLEX SUGAR |
| 04/03/2003 | WO2003027294A1 Glucose dehydrogenase |
| 04/03/2003 | WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027287A1 Kidney-specific urate transporter and gene thereof |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027280A1 Gene overexpression system |
| 04/03/2003 | WO2003027274A2 Purified polypeptides from pseudomonas aeruginosa |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027264A2 Coisogenic eukaryotic cell collections |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 04/03/2003 | WO2003027249A2 High-protein-phenotype-associated plant genes |
| 04/03/2003 | WO2003027245A2 CONVERSION OF RED BLOOD CELLS A, B, AND AB USING a-N-ACETYLGALACTOSAMINIDASES AND a-GALACTOSIDASE |
| 04/03/2003 | WO2003027240A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor |
| 04/03/2003 | WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein |
| 04/03/2003 | WO2003027233A2 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027147A2 Human coagulation factor vii polypeptides |
| 04/03/2003 | WO2003027145A1 Cell death inducer, cells and animals expressing the same and method of screening anti-cell death remedy |
| 04/03/2003 | WO2003027143A2 Gene and protein relating to hepatocellular carcinoma |
| 04/03/2003 | WO2003027141A1 Plant polypeptides and polynucleotides encoding same |
| 04/03/2003 | WO2003026767A2 Lysin-deficient bacteriophages having reduced immunogenicity |
| 04/03/2003 | WO2003026690A1 Incapacitated whole-cell immunogenic bacterial compositions |
| 04/03/2003 | WO2003002722A3 T cell regulatory genes and methods of use thereof |
| 04/03/2003 | WO2002088338A3 Method for replicating the hepatitis c virus |
| 04/03/2003 | WO2002081523A3 Method for preparing and selecting antibodies |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002066649A3 ANTI-INTERFERON-α ANTIBODIES |
| 04/03/2003 | WO2002066513A3 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof |
| 04/03/2003 | WO2002059306A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/03/2003 | WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/03/2003 | WO2002042444A8 Fungal gene cluster associated with pathogenesis |
| 04/03/2003 | WO2002040670A3 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain |